• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次完全缓解的急性髓系白血病患者接受非冷冻自体骨髓移植的大剂量化疗。

High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission.

作者信息

Koeppler H, Pflueger K H, Wolf M, Weide R, Havemann K

机构信息

Department of Internal Medicine, Philipps-University, Marburg, FRG.

出版信息

Haematol Blood Transfus. 1990;33:699-701. doi: 10.1007/978-3-642-74643-7_127.

DOI:10.1007/978-3-642-74643-7_127
PMID:2323669
Abstract

Seven patients with acute myeloid leukemia (AML) in first complete remission were treated with escalating high doses of cyclophosphamide, etoposide, and cytosine arabinoside (Ara-C). In all patients autologous bone marrow preservation was performed prior to therapy. Bone marrow was stored in blood bags in a refrigerator for 48-72 h at 4 degrees C and then reinfused over a central line. All patients had a full hematological recovery. The mean time of neutropenia (neutrophils less than 500/microliters) was 14 days (range 9-24 days), and the mean time of thrombocytopenia (platelets less than 20,000/microliters) was 9 days (range 7-11 days). The nonhematological toxicity was tolerable with mild to moderate nausea/vomiting, mucositis and diarrhea, and so far not dose-limiting. Six patients remain in complete remission 17+, 9+, 5+, 5+, 4+, and 1+ months after autotransplantation. One patient relapsed 8 months after autotransplantation. High-dose chemotherapy with noncryopreserved bone marrow autotransplantation may be useful as intensified consolidation for patients with AML in first complete remission.

摘要

7例首次完全缓解的急性髓系白血病(AML)患者接受了递增剂量的环磷酰胺、依托泊苷和阿糖胞苷(Ara-C)治疗。所有患者在治疗前均进行了自体骨髓保存。骨髓保存在血袋中,于4℃冰箱中存放48 - 72小时,然后通过中心静脉导管回输。所有患者均实现了完全血液学缓解。中性粒细胞减少(中性粒细胞低于500/微升)的平均时间为14天(范围9 - 24天),血小板减少(血小板低于20,000/微升)的平均时间为9天(范围7 - 11天)。非血液学毒性可耐受,表现为轻至中度恶心/呕吐、黏膜炎和腹泻,目前尚未达到剂量限制。6例患者在自体移植后17 +、9 +、5 +、5 +、4 +和1 +个月仍处于完全缓解状态。1例患者在自体移植后8个月复发。非冷冻保存骨髓自体移植的大剂量化疗对于首次完全缓解的AML患者作为强化巩固治疗可能有效。

相似文献

1
High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission.首次完全缓解的急性髓系白血病患者接受非冷冻自体骨髓移植的大剂量化疗。
Haematol Blood Transfus. 1990;33:699-701. doi: 10.1007/978-3-642-74643-7_127.
2
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.对于首次完全缓解的成年急性髓性白血病患者,先进行大剂量阿糖胞苷体内净化,随后进行大剂量放化疗,并回输未净化的骨髓。
J Clin Oncol. 1996 Aug;14(8):2206-16. doi: 10.1200/JCO.1996.14.8.2206.
3
Autologous peripheral blood progenitor cell transplantation mobilized with high-dose cytarabine in acute myeloid leukemia in first complete remission.高剂量阿糖胞苷动员的自体外周血祖细胞移植用于急性髓系白血病首次完全缓解期。
Ann Oncol. 1998 Feb;9(2):151-7. doi: 10.1023/a:1008271624978.
4
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemia.中等剂量阿糖胞苷/米托蒽醌用于复发和难治性成人急性髓性白血病的缓解诱导,高剂量阿糖胞苷/米托蒽醌用于强化巩固。
Haematol Blood Transfus. 1990;33:333-8. doi: 10.1007/978-3-642-74643-7_63.
5
Autologous bone marrow transplant in acute myeloid leukemia in first remission.
J Clin Oncol. 1993 Feb;11(2):314-9. doi: 10.1200/JCO.1993.11.2.314.
6
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia.高剂量自体骨髓支持治疗作为年轻急性髓性白血病患者首次缓解后的巩固治疗。
Ann Oncol. 2000 Aug;11(8):1007-15. doi: 10.1023/a:1008333903220.
7
Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
Eur J Haematol. 1997 Apr;58(4):233-40. doi: 10.1111/j.1600-0609.1997.tb01660.x.
8
[Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].[急性髓系白血病患者睾丸复发后接受大剂量白消安、依托泊苷和阿糖胞苷治疗后的第二次骨髓移植]
Rinsho Ketsueki. 1992 Mar;33(3):338-42.
9
The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.美法仑、环磷酰胺和阿糖胞苷联合作为急性白血病自体骨髓移植的预处理方案。
Chin Med J (Engl). 1996 Apr;109(4):304-7.
10
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group.成人急性髓性白血病强化维持治疗的随机对照研究:采用循环交替药物或重复疗程诱导型化疗——欧洲癌症研究与治疗组织白血病协作组的AML-6试验
Haematol Blood Transfus. 1990;33:277-84. doi: 10.1007/978-3-642-74643-7_50.

引用本文的文献

1
Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue.大剂量化疗及自体非冷冻骨髓挽救后的造血重建
Ann Hematol. 1991 Nov;63(5):253-8. doi: 10.1007/BF01698374.